DRUGS MADE IN AMERICA ACQUISITION II CORP. (DMIIR) Operating income
DRUGS MADE IN AMERICA ACQUISITION II CORP. (DMIIR) annual operating income history from SEC filings — each fiscal year as reported.
-$488,385FY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$488,385 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DMIIR financial trends
DMIIR RevenueDMIIR Net incomeDMIIR Net marginDMIIR Gross profitDMIIR Gross marginDMIIR Operating marginDMIIR Operating cash flowDMIIR Free cash flowDMIIR Capital expendituresDMIIR Return on equityDMIIR Stock buybacksDMIIR Dividends paidDMIIR Total assetsDMIIR Total liabilitiesDMIIR Shareholders’ equityDMIIR overview →